Drug Shortage Report for XIIDRA

Last updated on 2024-06-05 History
Report ID 228910
Drug Identification Number 02471027
Brand name XIIDRA
Common or Proper name XIIDRA 50MG/ML CONTAINER 02ML (12X5)
Company Name BAUSCH & LOMB INC
Market Status MARKETED
Active Ingredient(s) LIFITEGRAST
Strength(s) 5%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 12 X 5
ATC code S01XA
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-05-28
Actual start date 2024-05-28
Estimated end date 2024-06-03
Actual end date 2024-06-03
Shortage status Resolved
Updated date 2024-06-05
Company comments DISRUPTION IN DISTRIBUTION OF THE DRUG
Health Canada comments
Tier 3 Status No
Contact Address 1400 N GOODMAN STREET
ROCHESTER, NEW YORK
UNITED STATES 14609
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-06-05 French Compare
v5 2024-06-05 English Compare
v4 2024-05-29 English Compare
v3 2024-05-28 French Compare
v2 2024-05-28 English Compare
v1 2024-05-28 English Compare

Showing 1 to 6 of 6